Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 19];2(S1):S52. Available from: https://skin.dermsquared.com/skin/article/view/295